Top Markets
#1 Black Phoenix Black Phoenix +356.02%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +56.21%
#4 Akedo Akedo +48.10%
#5 Acurast Acurast +34.08%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.76%
#7 BasedHype BasedHype +25.78%
#8 Avantis Avantis +23.46%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.54%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Asarina Pharma AB (publ) Asarina Pharma AB (publ)

Asarina Pharma AB (publ)

ASAP
Clasificación en acciones #40860
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research... Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
Precio por acción
$0.00312742
Última sincronización: 2024-10-01
Capitalización bursátil
$70.81K
Cambio (1 día)
-21.83%
Cambio (1 año)
0.00%
País
SE
Comercio Asarina Pharma AB (publ) (ASAP)

Categoría

Healthcare
Ganancias de Asarina Pharma AB (publ) (ASAP)
Ganancias en Dec 2023 TTM: $-1.45M
Secondo gli ultimi rapporti finanziari di Asarina Pharma AB (publ), gli utili attuali della società sono $-1.45M. Nel 2022, la società ha registrato un utile di $-1.42M, un aumento con respecto a agli utili del 2021, che erano di $-4.23M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Asarina Pharma AB (publ) desde 2017 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-1.45M 0.00%
2023 $-1.45M 1.62%
2022 $-1.42M -66.40%
2021 $-4.23M -57.86%
2020 $-10.04M 18.85%
2019 $-8.45M 46.31%
2018 $-5.78M 46.17%
2017 $-3.95M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -365,136.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -135,090.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -208,103.35%
BE